Speaking Engagements (Staff, Collaborators, Strategic Partners)

Speaking Engagements (Staff, Collaborators, Strategic Partners)

2019

November 15 - 15, 2019
Cambridge, MA

Gigi Hirsch will present LEAPS

October 29 - 30, 2019
Bethesda, MD

Mark Trusheim will represent NEWDIGS

October 29 - 29, 2019
Boston, MA

Kay Larholt will present LEAPS

October 29 - 29, 2019
Washington, DC

Gigi Hirsch will present LEAPS 

October 2 - 4, 2019
Carlsbad, CA

Jane Barlow represents FoCUS 

September 26 - 26, 2019
New York City, NY

Mark Trusheim will represent FoCUS in a panel titled: Pricing Pressures for 2020 and Beyond

September 17 - 17, 2019
Cambridge, MA

Colin Young for the FoCUS Project

September 11 - 11, 2019
Washington, DC

Mark Trusheim will speak for FoCUS at this Duke-Margolis Center for Health Policy public workshop.

June 23 - 26, 2019
Orlando, FL

Jane Barlow for the FoCUS Project

June 14 - 14, 2019
Boston, MA

"Delve into the Evolving Reimbursement Landscape and Developments in Payer Policy"
Mark Trushiem for FoCUS

May 10 - 10, 2019
Rockville, MD

Mark Trusheim has been invited to speak.

https://aaadv.org/

May 4 - 4, 2019
New Orleans, LA

Mark Trusheim for FoCUS

April 4 - 4, 2019
Montreal, Ontario, Canada

Casey Quinn will represent the FoCUS Project in a Panel titled: HTA Reimbursement and Payment of Gene Therapy for Hemophilia

April 2 - 2, 2019
Cambridge, MA

12:00 PM Panel: Towards an “Agile” Regulatory Framework (45 mins)

Chaired by Gigi Hirsch, Massachusetts Institute of Technology

Paul Howard, Food and Drug Administration
Anne-Virginie Eggimann, bluebird bio
Ed Pezalla, Enlightenment Bioconsult
John Ferguson, Sanofi

March 27 - 27, 2019
Boston, MA

Mark Trusheim will present:
Precision Fiancing Framework and Pilots: MIT FoCUS Consortium Findings

March 25 - 28, 2019
San Diego, CA

Jane Barlow will represent the FoCUS Project

February 26 - 26, 2019
Cambridge, MA

Gigi Hirsch presented LEAPS:

From Bigger Data to Smarter Evidence

As health data increasingly scale and go digital, the prevailing attitude has been a big data approach, where whoever has the most data wins. However, the creation of vast amounts of data has not translated to useful evidence in many cases, particularly as biopharmaceutical innovation and healthcare systems evolve toward precision medicine, patient-centered innovation, and value-based reimbursement models where reliable, targeted, and fit-for-purpose evidence is key to matching the appropriate treatments to patients.  NEWDIGS is leading a... Learn more

2018

December 12 - 12, 2018
Cambridge, MA

Casey Quinn will present FoCUS learnings at the MIT Center for Biomedical Innovation's BioMANufacturing Program Summit

November 7 - 7, 2018
Boston, MA

Mark Trusheim, for NEWDIGS, facilitating working sessions for this Harvard-MIT Center for Regulatory Science and BIO joint workshop.

October 30 - 31, 2018
New York, NY

Kimberly Freeman, for FoCUS

October 29 - 29, 2018
Silver Spring, MD

Mark Trusheim, for NEWDIGS

The FDA Oncology Center of Excellence, in collaboration with theUCSF-Stanford Centers of Excellence in Regulatory Science and Innovation (CERSI) will hold a public workshop to explore clinical trial designs and innovations that will aid in ioptimizing outcomes in early breast cancer.

October 22 - 24, 2018
Washington, DC

Mark Trusheim, for NEWDIGS

More information here.

October 22 - 25, 2018
Orlando, FL

Jane Barlow for FoCUS
AMCP Nexus 2018

October 3 - 5, 2018
La Jolla, CA

Colin Young, FoCUS, presenting a poster on Pipeline Research

September 24 - 24, 2018
Washington, DC

Mark Trusheim
ASGCT Value Summit

September 11 - 11, 2018
Dallas, TX

R. John Glasspool for FoCUS
MCRA 2018 Conference

May 19 - 23, 2018
Baltimore, MD

Jane Barlow for FoCUS

May 10 - 10, 2018
New York, NY

Mark Trusheim

May 8 - 9, 2018
Stanford, CA

R. John Glasspool & Gigi Hirsch
Leaders in Global Healthcare & Technology

May 5 - 5, 2018
Chicago, IL

Mark Trusheim for FoCUS

 

May 2 - 2, 2018
Beverly Hills, CA

Mark Trusheim for FoCUS
"Paying for the High Cost of Cures"

March 26 - 26, 2018
Paris, France

R. John Glasspool & Casey Quinn for FoCUS

March 21 - 22, 2018
Budapest, Hungary

Ariel Stern and Mark Trusheim will facilitate a day of interactive discussions on MAPPS and the Adapt Smart consortium using NEWDIGS Scenario Design Lab methodology

2017

November 14 - 14, 2017
Washington, DC

(R. John Glasspool) Duke-Margolis Center for Health Policy Workshop

October 24 - 25, 2017
Washington, DC

(Kay Larholt) Real World Evidence Discussions & Overview of Related Projects

July 12 - 12, 2017
Boston, MA
May 24 - 24, 2017
Boston, MA

(Mark Trusheim) Adaptive Pathways and Platform Trials Discussion

May 10 - 11, 2017
Palo Alto, CA

(Gigi Hirsch) Panel: Real World Evidence: Hype or Reality? (John Glasspool, Moderator)

April 27 - 27, 2017
Boston, MA

(Mark Trusheim) Panel: Gene Therapy: Commercialization Readiness & Market Access Challenges

January 23 - 23, 2017
Washington, DC

(Gigi Hirsch) Panel: Adaptive Biomedical Innovations: The Way Forward (Stella Blackburn, Moderator)

2016

December 12 - 12, 2016
Washington, DC

hosted by the National Cancer Policy Forum. (G.K. Raju)

October 5 - 5, 2016
La Jolla, CA

“The Impact of a New Healthcare Model: What Do Payers Think of Gene Therapies?” (Mark Trusheim)

September 21 - 21, 2016
New York, NY

NBER Pre-Conference on Economic Dimensions of Personalized and Precision Medicine

June 29 - 29, 2016
Philadelphia, PA

“Europe and the US: Making Outcomes-Based Health Care Possible.” Details here. (Gigi Hirsch).

June 26 - 30, 2016
Philadelphia, PA

(Gigi Hirsch & Hans-Georg Eichler – Session Co-Chairs).

June 8 - 8, 2016
San Francisco, CA

“Curative Therapies: Aligning Policy with Science to Ensure Patient Access” (Mark Trusheim).

April 21 - 22, 2016
Duke University, Durham, NC

“Adaptive Pathways and Biomedical Innovation in the EU, US and Japan” (Ken Oye).

April 21 - 22, 2016
Washington, DC

“Adaptive Biomedical Innovation: Re-engineering How We Innovate” (Gigi Hirsch).

April 14 - 14, 2016
Basel, Switzerland
March 21 - 22, 2016
San Francisco, CA

co-sponsored by Silicon Valley Executive Network (SVEN), Decision Resources Group, and MIT Media Lab. “Adaptive Biomedical Innovation: Transforming Big Data Hype into Patient Value” (Tom Unger).

March 17 - 18, 2016
Amsterdam

Belgian Healthcare Knowledge Center (HKC) & WHO jointly sponsored Drug Pricing Scenarios Project (Report to be presented to Dutch EU Presidency in June 2016) – Part 1 (Mark Trusheim).

January 27 - 29, 2016
Washington, DC

Panel Debate on “Earlier Access vs. Safety?” (Hans-Georg Eichler & Ken Oye).